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ABSTRACT Chick muscle cultures infected with wild-
type Rous sarcoma virus form myotubes, but these myotubes
vacuolate and by day 6 most have degenerated, leaving only
large numbers of transformed mononucleated, replicating
cells. Muscle cultures infected with a temperature-sensitive
mutant (TS) at permissive temperatures behave as cells in-
fected with wild-type Rous sarcoma virus. TS-infected cells
reared for 8 days at nonpermissive temperature form con-
tracting myotubes, plus large numbers of fibroblastic cells. If
these cultures are lowered to permissive temperature, within
72 hr the myotubes vacuolate and degenerate, whereas the
mononucleated cells transform. If replicating TS-trans-
formed cells after 8 days at permissive temperature are shift-
ed to nonpermissive temperature, within 72 hr many cells
fuse and form contracting, post-mitotic myotubes. Creatine
kinase (ATP:creatine N-phosphotransferase, EC 2.7.3.2) levels
parallel the formation and degeneration of myotubes during
these temperature shifts. If the viral transforming gene is ex-
pressed in the post-mitotic myotubes it is lethal, whereas it is
not lethal if expressed in replicating precursor myogenic
cells. The viral gene expression at permissive temperatureblocks further myogenesis depending on the position of the
cells in the myogenic program. The virus does not cancel the
replicating, transformed myogenic cells' commitment to, or
position in, the myogenic lineage. When the transforming ac-
tion of the virus is suppressed, the normal myogenic program
resumes.
The question whether some events which control differen-
tiation can modulate the course of viral-induced transforma-
tion is an important one and the answer to this question may
throw some light on the mechanism of transformation as
well as differentiation. There are several reports that cells in
muscle cultures can be infected with either DNA or RNA vi-
ruses (1-6). However, muscle cultures, and even "muscle
clones" consist of a heterogeneous population of cells in dif-
ferent compartments of the myogenic and fibrogenic linea-
ges, and it is by no means clear whether these different phe-
notypes respond to the viruses in the same manner (7). For
example, when muscle cultures are treated with oncogenic
virus, does the virus transform both replicating myogenic
and post-mitotic myogenic cells? Will the post-mitotic nuclei
in infected myotubes integrate the virus, transcribe the viral
genome, and transform? Will normal, post-mitotic myotube
nuclei be induced to reenter the cell cycle and undergo mi-
tosis as claimed by some investigators (3, 6)? Clearly, an-
swers to these questions will contribute to understanding
myogenesis, and could provide a useful model for following
events responsible for transformation.
We have confirmed previous observations on the effect of
wild-type Rous sarcoma virus (RSV) on muscle cultures (5).
Replicating myogenic cells exposed to RSV fused to form
post-mitotic, multinucleated myotubes, but these myotubes
invariably vacuolated and degenerated within the next
72-96 hr. We have further demonstrated that the virus had
no visible effect on the post-mitotic myotubes at the time of
infection. By using a temperature-sensitive mutant (TS) we
have also demonstrated that the virus transformed replicat-
ing presumptive myoblasts and replicating fibroblasts. Re-
plicating myogenic cells transformed by a TS mutant did
not fuse at permissive temperature, but ceased replicating
and fused when shifted to nonpermissive temperature. TS-
mutant-infected cells reared at nonpermissive temperature
fused, but did not vacuolate. However, when such TS-infect-
ed cultures were shifted to the permissive temperatures,
within 72-96 hr virtually all the myotubes vacuolated and
degenerated, whereas all the mononucleated cells trans-
formed. The vacuolization and degeneration in myotubes is
probably an expression of the transforming activity of the
virus, rather than a response to a deleterious molecule re-
leased by transformed fibroblasts, for the vacuolization and
degeneration occur in the absence of transformed fibro-
blasts.
MATERIALS AND METHODS
Breast muscles were dissected from leukosis-free 10-day
chick embryos. The tissues were rendered into a suspension
of mononucleated cells by incubation in a 0.25% trypsin so-
lution and dissociated with a pasteur pipet. The cells (105/
ml) were cultured in collagen-coated culture dishes and the
uptake of [3H]thymidine ([3H]dThd) was followed radioau-
tographically as described in Bischoff and Holtzer (8). The
cultures were infected with the Prague strain of RSV (PR-
A), or with a temperature-sensitive mutant (TS mutant) of
this strain (9). The titer of RSV in focus-forming units was
determined as described by Vogt (10). Cells were infected
with approximately 5 focus-forming units per cell. This TS
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FIG. 1. Observe the huge numbers of mononucleated myogenic
and fibrogenic cells interspersed between the immature, multinu-
cleated myotubes. X300.
Abbreviations: RSV, Rous sarcoma virus; dThd, thymidine; BrdUrd,
bromodeoxyuridine; Ara-C, cytosine arabinonucleoside.
4051
-4052 Cell Biology: Holtzer et al.
FIG. 2. Virtually all myotubes in the infected cultures display
large vacuoles. These vacuoles range up to 10 ,um in size. X300.
mutant (LA 24) infects and transforms fibroblasts at the per-
missive temperature of 360; it will infect and produce virus,
but does not transform at the nonpermissive temperature of
410 (9). To determine whether replicating presumptive
myoblasts could be transformed, cultures were infected with
wild-type or TS mutant RSV immediately after plating.
After the cells were exposed to virus for 12 hr the cultures
were washed with growth medium and fed daily thereafter.
In some experiments 2-day-old cultures were exposed to cy-
tosine arabinonucleoside (Ara-C, 1 gg/ml) for the next 4-5
days, washed, and then grown in normal medium. This
treatment kills the great majority of replicating cells, but has
no detectable effect on post-mitotic cells (11).
Creatine kinase (ATP:creatine N-phosphotransferase, EC
2.7.3.2), which has been shown to be a good marker for fu-
sion (5) was assayed by the method of Oliver (12).
RESULTS
Virus-infected myotubes
Uninfected cultures, and cultures infected with wild-type
RSV or the TS mutant reared at permissive temperature
were essentially indistinguishable for the first 3 days in cul-
ture. The great majority of mononucleated cells replicated
at least once in the first 36 hr, and most of them replicated
again in the next 12 hr (8). By day 3, many myoblasts with-
drew from the cell cycle and began to fuse to form the mul-
tinucleated, post-mitotic myotubes (Fig. 1).
The multinucleated myotubes in the infected cultures,
though forming on schedule on day 3, invariably formed nu-
merous vacuoles by day 4 or 5 (Fig. 2). These vacuoles, 1 JAm
to over 4 Ism in diameter, filled the myotubes. The fact that
the vacuolated myotubes contract spontaneously demon-
strated that these cells had synthesized and organized myo-
sin, actin, and tropomyosin into functional myofibrils. As
these vacuolated myotubes gradually detached from the
substrate and degenerated, by day 5 or 6, few multinucleat-
ed myotubes were present in virus-treated cultures (Fig. 3),
whereas many thousands of contracting myotubes were
present in uninfected cultures. By this time creatine kinase
levels in virus-treated cultures have decreased to about 5%
of the control level (Fig. 4a). Essentially similar observations
were made by Easton and Reich (5) using the Schmidt-Rup-
pin strain of RSV.
Cells transformed by either the Prague strain of RSV or
the TS mutant were first detected microscopically toward
FIG. 3. Eight-day infected cultures consist almost exclusively
of mononucleated, replicating, transformed cells. These trans-
formed cells readily detach from the substrate. X300.
the end of day 3 and their numbers increased thereafter.
Transformed cells were distinguished from untransformed
cells by their rounded contours and the fact that they tended
to be multilayered, forming grape-like aggregates that were
readily dislodged from the substrate. Their cytoplasm was
honeycombed with small vacuoles approximately 1 jim in
diameter, and upward of 50 vacuoles were present in a cell.
By day 5 or 6 the majority of myotubes that had formed de-
generated, and all the surviving mononucleated cells in the
infected cultures exhibited the cytology of transformed cells.
The appearance of cultures transformed by the wild-type
RSV was indistinguishable from that of the cultures trans-
formed by the TS mutant at the permissive temperature.
To determine whether RSV would infect and transform
post-mitotic myotubes, 2-day-old cultures were exposed to
Ara-C for 4 days, washed, and then grown in normal medi-
um. This treatment kills the replicating mononucleated cells,
thus yielding cultures consisting almost exclusively of post-
mitotic myotubes. RSV was added to the resulting 6 day cul-
tures. The cultures were grown for another 7 days (Fig. 5).
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FIG. 4. (a) Cultures were initially grown at the permissive
temperature (360) in the presence of the TS mutant (virus) or ab-
sence of TS virus (control) for 8 days. Cells were then removed and
the creatine kinase was assayed as outlined in Materials and
Methods section. (b) Cultures were initially grown at the permis-
sive temperature in the presence of the TS mutant (virus) or ab-
sence of TS virus (control) for 8 days. These cultures were then re-
plated at initial densities, grown at nonpermissive temperature
(410), and fixed after 4 days, and creatine kinase was assayed.
Proc. Nat. Acad. Sci. USA 72 (1975)
Proc. Nat. Acad. Sct. USA 72 (1975) 4053
-^4_ - s.s__ VM ',
-TWkAf t, O _- ,. .1
FIG. 5. Eleven-day Ara-C-treated culture that had been ex-
posed to virus 5 days earlier. Note the absence of vacuoles in my-
otubes, as well as the absence of mononucleated myogenic and fi-
brogenic cells. X300.
During this period the myotubes did not vacuolate and did
not degenerate. However, small numbers of mononucleated
cells remaining after Ara-C treatment (less than 1% of con-
trol cultures) developed into sizable nests of replicating
transformed cells which could be observed among the com-
pletely normal myotubes. This indicates that the virus suc-
cessfully infected and transformed the replicating mononu-
cleated cells, though myotubes were not affected.
To determine whether the vacuolization and the degener-
ation observed in myotubes that had been assembled by in-
fected and/or transformed cells were due to the trans-
forming activity of the virus, the following experiments
were performed: Cultures were infected with the TS mutant
and grown at 41° (nonpermissive temperature) for 8 days.
These cultures contained large numbers. of normal-looking
mononucleated cells and large numbers of myotubes that
contracted spontaneously. Large vacuoles did not form in
these myotubes. However, when these cultures were shifted
to 360 (permissive temperature) virtually all the myotubes
vacuolated and degenerated within 48 hr. All of the mono-
nucleated cells displayed the morphology of transformed
cells after 48 hr. Since the transforming gene is temperature
sensitive, one can conclude that vacuolization of the my-
otube is the cell's response to activation of the viral trans-
forming genome. Though TS-infected myotubes at nonper-
missive temperature do not form massive vacuoles, never-
theless such myotubes can be distinguished from uninfected
myotubes. These differences will be described elsewhere.
To establish that vacuolization and degeneration of the
myotubes was due to the transforming activity of the viral
genome within the myotube, and not a response of the my-
otubes to molecules released by adjacent transformed fibro-
blasts, the following experiment was performed: Cultures
were infected with the TS mutant and grown at the nonper-
missive temperature. After the cultures were 36 hr old,
Ara-C was added and the cultures were grown in its pres-
ence for 6 days at the nonpermissive temperature. Myotubes
formed in these cultures but few mononucleated cells were
present. When these cultures were shifted to permissive
temperature, within 48 hr virtually all the myotubes vacu-
olated and degenerated, although no transformed fibroblasts
were present (Fig. 6).
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FIG. 6. Cultures were infected with the TS mutant and grown
at the nonpermissive temperature with Ara-C. After 8 days at the
nonpermissive temperature, the cultures were dropped to the per-
missive temperature. Note the characteristic vacuoles that ap-
peared after 48 hr. By 96 hr all the myotubes had degenerated.
X300.
Fusion of TS-transformed cells
Five-day-old infected cultures contain large numbers of re-
plicating transformed cells. To determine whether some of
these transformed cells were myogenic, the following exper-
iments were performed: Cultures were infected with the TS
mutant and grown at the permissive temperature. By day 5
most of the myotubes that had formed vacuolated and de-
generated, so that by day 8 only transformed mononucle-
ated cells were present. These TS-transformed cells incorpo-
rated [3H]dThd in a manner indistinguishable from trans-
formed chick fibroblasts. These cultures, which were main-
tained for another 2 days at permissive temperature, were
then subcultured, replated at the initial density, and shifted
to nonpermissive temperature. Within the next 48 hr many
of the formerly transformed cells fused and formed large
numbers of contracting myotubes. By 96 hr such cultures
have creatine kinase greater than 6-fold that of subcultures
of their uninfected counterparts (Fig. 4b). It should be
pointed out that in the uninfected muscle cultures fusion
peaks around day 4 or 5, and relatively few cells fuse on day
7 or 8. These experiments demonstrate that the active trans-
forming gene keeps the myogenic cells in the cell cycle.
Such transformed myogenic cells "remember" their position
in the myogenic lineage, and are able to express it, for at the
nonpermissive temperature they withdraw from the cell
cycle and fuse as would normal myoblasts.
That the myotubes that formed when TS-transformed
cells were elevated to nonpermissive temperatures harbored
virus was shown by then lowering these cultures to permis-
sive temperatures. Within 48 hr the myotubes that formed
by the fusion of transformed cells at the nonpermissive tem-
perature vacuolated and degenerated when shifted down.
The virus used in these experiments has a genetic defect
at the gene responsible for transformation so that the TS-in-
fected cells transform only at the permissive temperature.
On the other hand, infected fibroblasts produce virus even
at the nonpermissive temperatures. Therefore, it was of in-
terest to determine if myotubes that had been infected with
the TS virus as mononucleated cells would or would not pro-
duce virus at the nonpermissive temperatures. Preliminary
experiments with the Ara-C-treated cultures indicate that if
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the infected myotubes produce any virus, it is less than Aoo
of the equivalent transformed fibroblasts. However, even
this low value may be due to the virus produced not by the
myotubes but by the small numbers of mononucleated cells
present in Ara-C cultures.
DNA synthesis
Nuclei in multinucleated myotubes normally never again
enter S and so never divide (13, 14). However, there are re-
ports that nuclei in virus-infected myotubes can be induced
to synthesize DNA and even enter metaphase (1-3, 6). To
determine whether wild-type RSV or the TS mutant could
induce normally post-mitotic myoblasts or myotubes to
reenter the cell cycle, a series of autoradiographic experi-
ments was performed: Cultures infected with either virus
were exposed to [3H]dThd for 1 hr on days 3, 4, 5, or 6 at ei-
ther permissive or nonpermissive temperatures. In no in-
stance did the nuclei in myotubes incorporate the label.
Normal presumptive myoblasts are obligated to synthesize
DNA and pass through a quantal cell cycle to yield post-mi-
totic myoblasts capable of fusing (19, 20, 23). To determine
whether transformed myogenic cells had to replicate prior
to fusing, TS-transformed cells were shifted to permissive
temperature and [3H]dThd was added to the medium. After
48 hr the cells were prepared for autoradiography. Approxi-
mately 25% of the nuclei in the myotubes that formed were
unlabeled. However, it is still not clear whether those cells
that fused without replicating would have withdrawn from
the cell cycle even without fusing. Further experiments are
required to clarify this intriguing issue (23).
DISCUSSION
In addition to infecting and transforming fibroblasts, RSV
has been reported to infect and transform iris-epithelial cells
and pigment cells (15), cells derived from hematopoietic or-
gans (16), and some undefined embryonic retinal cells (17).
Our experiments demonstrate that presumptive myoblasts
can be infected and transformed. Pending further experi-
ments we cannot state whether failure to observe changes in
pre-formed myotubes after exposing them to virus was due
to failure of the virus to penetrate the myotubes, or to ini-
tiate infection, or to be integrated into the post-mitotic host
nuclei.
In replicating myogenic and fibrogenic cells the trans-
forming gene causes the morphological changes typically as-
sociated with transformed cells. That vacuolization and de-
generation of the myotubes is due to the virus within the
myotubes, and is not a secondary response to products of ad-
jacent mononucleated cells, was shown by the behavior of
infected cells in Ara-C-treated cultures. The myotubes in
these cultures did not vacuolate and degenerate at 41°, but
promptly did so when shifted to 360, although transformed
fibroblasts were essentially absent. It is clear that the molec-
ular events responsible for vacuolization and degeneration of
the myotubes were caused by the transforming gene product
of RSV in the absence of proliferation in the host cells. This
point was strengthened by the fact that the time of appear-
ance of the vacuoles in the TS-infected myotubes following
temperature shift down roughly corresponded to the time
biochemical changes are observed in TS-infected fibroblasts
which are subjected to a similar shift to the permissive tem-
perature. In myotubes vacuolization is followed by degener-
ation. Although vacuolization occurs in mononucleated cells
as well, they survive and continue to replicate. This might
only mean that the latter could successfully mobilize mem-
branous components to keep up with the transforming gene
action, whereas comparable synthetic activity cannot occur
in myotubes. Alternatively, activity in the post-mitotic my-
otubes might lead to forbidden cytoplasmic or nuclear activ-
ity. For example, if viral genomes integrated into host nuclei
must periodically replicate and if myotube nuclei are inca-
pable of synthesizing DNA, this might constitute a forbid-
den cytoplasmic-nuclear exchange that would lead to the
death of the cell.
It is possible that the viral genome in the myotube exists as
a provirus DNA without being integrated into the nuclei, as
in the case of ethidium bromide treated fibroblasts (18). Ac-
cordingly, it will be of interest to determine by the appropri-
ate hybridization experiments whether the viral genome has
or has not been integrated into the post-mitotic myotube
chromosomes.
The formation of myotubes during the first 3 or 4 days of
the primary virus-treated cultures, but not thereafter, merits
discussion, particularly regarding changes in the cell surface
of myogenic cells concerned with fusion (19, 20). It is proba-
ble that not all of the myogenic cells are infected and trans-
form at precisely the same time. Furthermore it is known
that approximately 20% of the original inoculum consists of
cells that fuse without replicating (8, 20). From the stand-
point of cell differentiation these findings suggest that, de-
pending on the position of the cell in the myogenic program,
further development can be superseded by the transforming
activity of the virus. If the cell is prepared to fuse, fusion
might occur before full expression of the transforming ge-
nome so alters the cell surface so as to preclude fusion. Nev-
ertheless, the resulting myotube will vacuolate and degener-
ate when the transforming genome is finally expressed. In
brief, even if suppressed by the action of the transforming
gene, the epigenetic program of the transformed myogenic
cell is stable enough as a phenotype to persist. These trans-
formed cells do not lose their previously acquired commit-
ment to, and position in, the myogenic lineage.
Phenomenologically, the TS-transformed myogenic cells
and bromodeoxyuridine (BrdUrd)-suppressed myogenic
cells are markedly similar (8, 21). BrdUrd blocks not only
the withdrawal from the cell cycle and fusion into my-
otubes, but also the initiation of synthesis of such myoblast
luxury proteins as skeletal myosin heavy and light chains,
tropomyosin, and possibly the actin destined for the thin
filaments of myofibrils (14, 23, 26, 29). The block by these
agents is readily reversible, and it is unlikely that BrdUrd or
a viral transformation product suppresses the individual
structural genes for myosin, actin, creatine kinase, and the
genes regulating the events required for fusion. These obser-
vations coupled with those made on the effects of BrdUrd on
erythrogenic cells (21, 22, 27, 28) suggest the existence of
BrdUrd-sensitive "master switch" loci (21-23, 26, 28) on
chromosomes. Such loci, it has been postulated, would make
available for transcription just those unique groupings of
structural genes which characterize the metabolic options of
that particular cell type. Neither the blocking effect of
BrdUrd nor the activity of the transforming gene impair the
position in the lineage of the myogenic cell. Thus, when the
transforming action of the virus is suppressed by shifting to
the nonpermissive temperature, or when BrdUrd in the cell's
chromosomes is diluted by new DNA synthesis, in both in-
stances read-out of the normal myogenic program resumes.
TS-transformed myogenic cells and Friend erythroleukemic
cells (30), to a degree, mimic BrdUrd-suppressed myogenic
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and BrdUrd-suppressed erythrogenic cells. It will be of in-
terest to determine whether the sites of viral gene integra-
tion into the chromosomes of myogenic cells and erythroge-
nic spleen cells correspond to those sites sensitive to BrdUrd
and whether such sites have the properties of "master
switch" loci (23).
Previous reports that nuclei in myotubes infected with
RSV or simian virus 40 were induced to enter S and that
such nuclei proceeded into mitosis must be reconsidered
(1-3, 6). What these investigators interpreted as DNA syn-
thesis and metaphase chromosomes, others (13, 23) have in-
terpreted as the incorporation of [3H]dThd associated with
DNA repair and/or nuclear pulverization (24).
The data in this paper contribute two points regarding
basic controls in neoplastic cells: (1) The epigenetic program
of RSV-transformed myogenic cells is blocked, not abrogat-
ed. Blocking viral oncological activity by shifting tempera-
ture allows the previously transformed, continuously repli-
cating cell to withdraw from the cell cycle; (2) If cells in the
terminal compartment of the myogenic lineage are obligat-
ed to irreversibly turn off DNA synthesis, then the cell of or-
igin of the rhabdomyosarcoma is likely to be a transformed
presumptive myoblast, rather than a terminal myoblast (25).
Note Added in Proof. Transformation of myogenic cells by Rous
sarcoma virus has recently been carried out in other laboratories
also (31, 32).
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